Treatment of dyslipidaemias
EBM Guidelines
Oct 1, 2021 • Latest change Feb 12, 2024
Table of contents
Extract
- The aim of treatment is to:
- reduce the risk of atherosclerotic diseases
- In people with no arterial disease, the risk can be assessed with a calculator, such as the HeartScore® https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/HeartScore1.
- prevent worsening of arterial disease.
- reduce the risk of atherosclerotic diseases
- Lifestyle modification is of primary importance in all patients.
- Secondary hypercholesterolaemia (associated with hypothyroidism, for instance) must be excluded before starting medication.
- The general goal of treatment is to lower plasma LDL cholesterol levels to:
- below 3.0 mmol/l in low risk patients
- below 2.6 mmol/l in moderate risk patients
- below 1.8 mmol/l in high risk patients
- below 1.4 mmol/l, as far as possible, in very high risk patients.
- In hypertriglyceridaemia, triglyceride levels must be below (5–)10 mmol/l to reduce the risk of pancreatitis.
Search terms
Aged, Arteriosclerosis, Atherosclerosis, Blood lipids, Cardiology, Cholesterol, Cholesterol, HDL, Cholesterol, LDL, Coronary Disease, Diabetes Mellitus, Dyslipidaemia, Dyslipidemia, E78*, Endocrinology, Hypercholesterolemia, Hyperlipidemia, Hyperlipoproteinemia Type IV, Internal medicine, Intracranial Arteriosclerosis, Lipids, Statin, Statins, Triglycerides, hypercholesterolemia, secondary